/Investor DB

Sazze — 2026 Investments

3 investments dated 2026 · listed companies and verified rows first · show all

Airbilityairbility.co.krinSep 2026 · $4.7M

Airbility is a South Korean aircraft developer working on high-speed electric vertical take-off and landing vehicles.

Mobility & Transportation

Jinmo LeeinMinyoung Ahn(Founder)in

Co-investors500 GlobalIndustrial Bank of KoreaPrimer Sazze PartnersStonebridge Ventures

Nitranitra.comin𝕏Apr 2026 · $187M

Nitra provides a card, lending, and back-office platform built specifically for independent medical practices including ophthalmology, dental, aesthetics, and fertility clinics.

Enterprise SoftwareFintechHealthtechNew York, US

Tim Hwang(CEO)in

Co-investorsAAF Management Ltd.AppWorks VenturesDunamu & PartnersExpaFoundersXFoundersX Ventures+26 more

TippingPoint Biosciencestippingpointbiosciences.cominMar 2026 · $4.5M

TippingPoint Biosciences is a therapeutics company developing a drug discovery platform that targets unstructured regions in chromatin proteins to treat diseases caused by dysfunctional genome chromatin packaging, with a focus on cancer.

BiotechDeep TechHealthtechSan Francisco, US

Laura Hsieh(Founder & CEO)in

Co-investorsFREEFLOWSOSVBrightEdgeEmpath VenturesStoryHouseXEIA Venture Partners

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.